Musk is waging a feud to seize control of Twitter, which Twitter does not own. Twitter has contacted a lawyer in the most straightforward way possible: through the business that sent a poison pill. The business then filed a lawsuit against Musk in an effort to compel the merger.
When the Twitter complaint surfaced, it appeared, at first reading, that someone had a lot of fun putting it together, in part due to the inclusion of a screenshot of Musk’s clumsy tweet:
I enjoy a good court case. Can Twitter succeed? Tom Redburn, the head of securities litigation at Lowenstein Sandler, finishes laughing at the frustration and adds, “He signed a contract, and it says what it says.
Musk’s ability to back out of the agreement is limited since he waived due diligence, which is the practice of researching the firm you’re buying before you commit to an acquisition. Redburn asserts, “That’s a difficult situation for a buyer to be in.”
In fact, according to Redburn, Delaware’s Chancery Court, which is frequently utilized by corporations, has a reputation for being quite indifferent to buyer’s remorse. In one well-known instance, a buyer was able to effectively back out of a deal due to fraud.
Due to Akorn’s concealment of several financial issues, medical organization Fresenius, well known for its US dialysis service, was able to avoid purchasing the pharmaceutical in 2018. Fresenius was able to demonstrate that Akorn falsified their statistics, according to Redburn. That would put a damper on a merger somewhat.
To read our blog on “Elon Musk may decide against purchasing Twitter, which is becoming increasingly likely” click here.
